The U.S. diagnostic imaging market is valued at approximately $150 billion in 2025 and encompasses an estimated 600 million or more procedures annually. But where a scan is performed matters enormously — for the patient’s bill, the provider’s bottom line, and the trajectory of healthcare spending.

Diagnostic imaging is delivered across four distinct facility types: hospital-based radiology departments, freestanding imaging centers, urgent care clinics, and mobile imaging providers. Each operates with a different business model, cost structure, clinical capability, and growth trajectory. Three forces are converging to reshape this landscape: imaging volume migrating from hospitals to lower-cost outpatient settings, federal reimbursement policy targeting the pricing gap between facility types, and private equity investment accelerating consolidation among independent providers.

Hospital-Based Radiology: The Dominant Incumbent

Hospital radiology departments perform the majority of all U.S. imaging volume and offer the broadest clinical capability of any facility type — full-spectrum modality suites including MRI, CT, X-ray, ultrasound, PET/CT, mammography, fluoroscopy, nuclear medicine, and interventional radiology. Imaging contributes a substantial amount to outpatient profit for many hospital systems, making it arguably their single most important outpatient revenue engine.

The financial mechanics are distinctive. Hospital outpatient departments (HOPDs) generate two separate charges — a facility fee and a professional fee — which is why the same scan costs dramatically more at a hospital than elsewhere. HOPD imaging prices can run significantly higher compared to freestanding centers. A procedure costing $600 at an independent center can range from $1,000-1,800 at a hospital.

This pricing advantage is under sustained policy pressure. CMS has expanded site-neutral payment cuts across multiple service categories, and the CY 2026 OPPS rule finalized site-neutral rates for drug administration services. More consequentially, CMS has formally requested information on extending site-neutral payment to imaging without contrast — signaling that diagnostic imaging reimbursement reform may be next. The Congressional Budget Office projects comprehensive site-neutral reform could save $157 billion over ten years.

In response, many health systems are building or acquiring freestanding outpatient imaging centers through joint ventures with established operators, seeking to capture volume migrating to lower-cost settings while a growing share of major imaging center chains become hospital-owned or affiliated.

Freestanding Imaging Centers: The Market’s Growth Engine

Freestanding imaging centers in the U.S. handle the second most imaging volume and generate an estimated $24-27 billion in annual revenue. Their defining competitive advantage is cost: they typically charge 40–65% less than hospitals for equivalent procedures, with no facility fee, lower overhead, higher equipment utilization, and a single transparent bill.

Most centers operate MRI, CT, X-ray, ultrasound, and mammography, with some offering PET/CT. They generally do not handle emergencies, complex interventional procedures, or integrated inpatient workflows — their sweet spot is scheduled outpatient imaging.

The ownership landscape for freestanding centers is evolving rapidly. RadNet, the largest publicly traded provider, operates 418 centers and reported record 2025 revenue of $2.04 billion. Private equity has become a dominant force beyond RadNet: SimonMed Imaging (170+ locations), RAYUS Radiology (140 fixed sites), Capitol Imaging Services (57+ locations), and Envision Radiology (100+ locations after acquiring Rezolut in late 2025) are all PE-backed. By the end of 2023, 12% of all U.S. radiologists were PE-employed — up from just 1% a decade earlier.

Urgent Care and Retail Clinics: A Narrow but Expanding Role

As of mid-2025, nearly 12,000 active urgent care clinics operate in the U.S., with the market estimated to be $34-38 billion in annual revenue. About 90% offer digital X-ray, but capabilities drop off sharply beyond that — ultrasound is available at an estimated 2- 10% of centers, CT at fewer than 2%, and MRI is essentially absent. Retail clinics like CVS MinuteClinic generally do not offer imaging at all.

Urgent care fills a useful but limited niche: speed and convenience for a quick X-ray to rule out a fracture. For anything beyond basic radiography, it serves as a triage point referring patients to hospitals or freestanding centers.

Mobile Imaging: Bringing the Scanner to the Patient

Mobile imaging providers bring MRI, CT, PET/CT, mammography, and X-ray equipment on specially outfitted trucks directly to facilities that need them. The U.S. mobile imaging market is estimated to be growing at roughly 4.5% annually.

The model is contract-based — hospitals, nursing homes, and rural clinics that cannot justify permanent installations contract for scheduled imaging days. Akumin (owned by Stonepeak) operates the nation’s largest mobile fleet, serving over 800 hospitals across 46+ states after its $820 million acquisition of Alliance HealthCare Services. Shared Medical Services recently deployed the first mobile helium-free MRI and TridentCare sends portable X-ray and ultrasound equipment to patients’ bedsides in nursing homes and assisted living facilities, serving 5,000+ locations.

Mobile imaging’s greatest value is access. Dana-Farber Cancer Institute’s mammography van has screened over 24,000 women since 2002, predominantly from underserved communities. MRI is the largest mobile revenue category at 37% of the market, while PET/CT and Ultrasound are the fastest growing subsegments.

The Forces Reshaping Every Arena

Four cross-cutting forces will shape the industry’s trajectory. Reimbursement reform favors lower-cost settings as CMS expands site-neutral policies, with imaging explicitly in the crosshairs. Workforce shortages are acute, a significant number of the nation’s estimated 41,000 radiologists are over 55, and technologist vacancy rates hit all-time highs in 2025 (CT at 19.4%, MRI at 17.4%). AI adoption is becoming a competitive differentiator, with over 1,250 FDA-authorized AI medical devices in radiology and large operators like RadNet’s DeepHealth subsidiary investments approaching $600 million in AI acquisitions. Consolidation continues to accelerate, with PE completing over a dozen imaging deals in 2025 and health systems acquiring outpatient centers to retain migrating volume.

Conclusion

The U.S. diagnostic imaging market is four overlapping arenas with distinct economics and competitive positions. Hospitals offer unmatched breadth but face mounting reimbursement pressure. Freestanding centers are the growth engine, powered by 50%+ cost advantages and PE investment. Urgent care adds imaging at the margins. Mobile fills critical access gaps for underserved populations.

The forces ahead — site-neutral reform, AI capability, workforce constraints, and consolidation — favor scale, capital efficiency, and adaptability. The providers that navigate this convergence most effectively will capture disproportionate share of a market on track to exceed $240 billion within the next decade.